Theme — agents

Items in corpus: 21

Papers

• Agentic AI and in silico team science — Li et al., Nature Biotechnology, 2026
  Position paper behind the agentic-FM intersection.
• DeepRare — agentic system for rare-disease diagnosis with traceable reasoning — Zhao et al., Nature, 2026
  Multi-agent LLM diagnosis system that outperformed physicians on rare-disease cases — the agentic-clinical proof point.
• VCWorld — biological world model for virtual cell simulation — Shuangjia Zheng lab et al., arXiv, 2025
  White-box LLM-driven simulator: stepwise mechanistic reasoning, SOTA on drug-perturbation benchmarks. Anti-black-box alternative.

Tools

• rBio — reasoning model trained on TranscriptFormer — CZ Biohub, 2025
  Agent that REASONS OVER a virtual cell as a verifier.
• VCHarness — autonomous virtual-cell builder — bioRxiv (BioMap), 2026
  Agent that BUILDS virtual-cell models end to end.
• CellVoyager — autonomous comp-bio agent — Nature Methods, 2026
  Agent that ANALYSES single-cell data with the FM as substrate.
• MedAgentGym
  Agentic environment / benchmark for training and evaluating medical AI agents.
• PathChat-DX — Mahmood Lab, 2025
  First generative-AI pathology tool with FDA Breakthrough Designation (Jan 2025).
• PathChat / PathChat-2 / PathChat-DX — Nature, 2024
  Mahmood vision-language pathology assistant; DX got FDA Breakthrough.
• VCHarness (GenBio AI) — GenBio AI
  Genbio's autonomous virtual-cell builder agent — see the paper too.
• VCR-Agent
  Virtual-cell reasoning agent — name only.
• PathChat-2 — Mahmood Lab, 2026
  Successor instruction-tuned pathology assistant (>1M pairs).
• BenchSci
  Life-science research platform — biology-paper search agent.
• Owkin Pathology Explorer in Claude — Owkin, 2026
  Agent using pathology FMs inside Claude's clinical workflow — production agent-using-FM example.
• DrugReflector — 2026
  2026 AI drug-screening foundation model picked up in industry coverage — provenance still firming up.

Organisations

• BioMap Research + MBZUAI — Le Song & Eric Xing
  China/Middle-East virtual-cell competitor (VCHarness, xTrimo).

People

• Bo Wang — U. Toronto / Vector
  scGPT PI; 2026 pivot to agentic AI (X-Cell).
• Le Song / Eric Xing — BioMap + MBZUAI
  VCHarness; autonomous virtual-cell direction from China.

Commentary

• From equations to agents — the AI virtual cell reshaping precision oncology — The Innovation Oncology (perspective), 2026
  Clinical-oncology framing of the AIVC story.
• Latent Space podcast — Swyx & Alessio
  AI podcast that books biology-FM founders.

Move

• PathChat-DX FDA Breakthrough Designation — 2025
  First generative-AI pathology tool to win FDA Breakthrough.

---

Regenerated 2026-05-15 from a 277-item corpus by resourcelib-views.